Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Tissue Engineering & Bioprinting: Research to Commercialization

Jonathan Butcher's Biography



Jonathan Butcher, Associate Professor, Biomedical Engineering, Cornell University

Jonathan is an Associate Professor in the Department of Biomedical Engineering at Cornell University, where he has taught since 2007. Jonathan Butcher received his BS and MS in Mechanical Engineering at the University of Virginia in 2000, and a PhD in Mechanical Engineering from Georgia Tech in 2004. He then conducted postdoctoral training in cardiac developmental biology at the Medical University of South Carolina. Jonathan’s research focuses on understanding how tissue assembly and maturation during embryonic development are controlled by mechanical signaling, and in turn how these developmental signaling pathways are reactivated in postnatal diseases. He applies this information to engineer new regenerative and therapeutic strategies for cardiovascular diseases. His research is supported by grants from the National Institutes of Health, National Science Foundation, American Heart Association, and The Hartwell Foundation. Jonathan was recognized with the Lillehei Prize by the Society for Heart Valve Disease in 2007, and the Rita Schaffer Young Investigator Award of the Biomedical Engineering Society in 2009. Jonathan has also been recognized by the National Academy of Engineering, Frontiers in Engineering (2010) and Engineering Education (2011) Programs, as well as honored with the Swanson Teaching Award at Cornell in 2011. Jonathan has been a member of TERMIS since 2003, and in addition to chairing scientific session has served on the Scientific Committee for the TERMIS World Congress in Vienna in 2012. He and his wife Christine have five children.

Jonathan Butcher Image

3D Biofabrication of Complex Living Cardiovascular Tissues: Past, Present, Future

Monday, 9 February 2015 at 11:30

Add to Calendar ▼2015-02-09 11:30:002015-02-09 12:30:00Europe/London3D Biofabrication of Complex Living Cardiovascular Tissues: Past, Present, FutureTissue Engineering and Bioprinting: Research to Commercialization in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com

Cardiovascular disease remains a leading cause of death worldwide. Despite their potential, achieving functional living tissue replacements has been an elusive “Holy Grail” for the last two decades.  Among the challenges is that natural tissues are highly complex, hierarchical structures that are difficult to replicate. Tissue biofabrication technology, in particular 3D tissue printing, has made significant strides over the past 5 years to close this gap. 3D tissue printing has the capacity to prescribe both macro and microstructural environmental cues that are essential for coordinating whole tissue function. We discuss recent findings on two prominent applications: trileaflet heart valves and vascularized tissue flaps.


Add to Calendar ▼2015-02-09 00:00:002015-02-10 00:00:00Europe/LondonTissue Engineering and Bioprinting: Research to CommercializationTissue Engineering and Bioprinting: Research to Commercialization in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com